Role of phaltrikadi kwath in Diabetic dislipidemia

“A Randomized controlled crossover clinical study to evaluate the efficacy of Phaltrikadi Kwath in patients with Diabetic dyslipidemia. ? - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058859

Enrollment

122

Registered

2023-10-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E781- Pure hyperglyceridemia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pre diagnosed patients Type 2 diabetes mellitus patient who are already on any type of oral hypoglycemic agent 2)Patients with HbA1c value more than 6.5% 3)Age group – 18 to 80 years 4)Patients of either Gender 5)Triglyceride levels > 150 mg/dl and 6)LDL levels >100mg/dl and HDL

Exclusion criteria

Exclusion criteria: 1)Insulin dependent Diabetes mellitus 2)Any major systemic diseases like Carcinoma, Tuberculosis etc. 3)K/C/O- Neuropathic ulcer, Peripheral Vascular disease. 4)K/C/O Immunosuppressed patients on immunosuppressive drugs. 5)Malignancy disease. 6)Patient on steroid therapy. 7)Pregnant & Lactating women 8)Unable to provide written informed consent

Design outcomes

Primary

Measure	Time frame
Primary end point Decrease in Triglyceride levels Timepoint: lipid profile will be done on1st day ,60th day,75th,135th day	—

Secondary

Measure	Time frame
Secondary end point Effective control of glycaemic Index Timepoint: blood sugar levels will be done on 1st day 60th day, 75th day and 135th day HbA1c will be done on 1st day and 90th day	—

Countries

India

Contacts

Public ContactMAHESH HARISHANKAR PANDEY

Dr DY Patil College Of Ayurveda and Research Center Pimpri PUNE 411018

gunvantayurved@gmail.com9422321955

Outcome results